US Patent Issued to The Hong Kong Polytechnic University on Dec. 2 for "System and methods for precision tumor delineation in cancer treatment or diagnosis for subjects with carcinoma based on contrast agent-free, virtual contrast-enhanced MRI data" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,488,877, issued on Dec. 2, was assigned to The Hong Kong Polytechnic University (Hong Kong).

"System and methods for precision tumor delineation in cancer treatment or diagnosis for subjects with carcinoma based on contrast agent-free, virtual contrast-enhanced MRI data" was invented by Jing Cai (Hong Kong), Wen Li (Hong Kong) and Tian Li (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a system and method for precision tumor delineation in cancer treatment or diagnosis for subjects with carcinoma, in particular, nasopharyngeal carcinoma, based on contrast agent-free, virtual contrast-enhanced MRI data (VCE-MRI) s...